Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 239,658 shares at $51.15 ($12.2M) on 2022-04-13, disclosed to the SEC on 2022-04-14.
Open-market sale of $12.2M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.05 | 2,486 | $124K | 1.0% |
| 2 | $50.05 | 2,486 | $124K | 1.0% |
| 3 | $50.05 | 17,469 | $874K | 7.1% |
| 4 | $50.05 | 17,469 | $874K | 7.1% |
| 5 | $51.15 | 10,741 | $549K | 4.5% |
| 6 | $51.15 | 10,741 |
| $549K |
| 4.5% |
| 7 | $51.15 | 75,465 | $3.9M | 31.5% |
| 8 | $51.15 | 75,465 | $3.9M | 31.5% |
| 9 | $52.08 | 13,668 | $712K | 5.8% |
| 10 | $52.08 | 13,668 | $712K | 5.8% |
| Total | $51.07 avg | 239,658 | $12.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |